search
Back to results

Group-Based Contingency Management for Substance Abuse Treatment - 1

Primary Purpose

Substance Abuse

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Contingency management
Sponsored by
UConn Health
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Substance Abuse focused on measuring Contingency management, Substance abuse treatment

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria: age > 18 years current DSM-IV diagnosis of cocaine, opioid or alcohol abuse or dependence willing to provide breath and urine samples for 12 weeks English speaking willing to sign informed consent Exclusion criteria: serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) dementia (<23 on the Mini Mental State Exam; Folstein et al. 1975) in recovery from pathological gambling

Sites / Locations

  • University of Connecticut Health Center

Outcomes

Primary Outcome Measures

Drug use
Retention

Secondary Outcome Measures

Full Information

First Posted
November 3, 2005
Last Updated
November 17, 2011
Sponsor
UConn Health
Collaborators
National Institute on Drug Abuse (NIDA)
search

1. Study Identification

Unique Protocol Identification Number
NCT00249717
Brief Title
Group-Based Contingency Management for Substance Abuse Treatment - 1
Official Title
Group-Based Contingency Management for Substance Abuse Treatment
Study Type
Interventional

2. Study Status

Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
May 2005 (undefined)
Primary Completion Date
January 2010 (Actual)
Study Completion Date
January 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
UConn Health
Collaborators
National Institute on Drug Abuse (NIDA)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the efficacy of prize-based contingency management (CM) when administered exclusively in groups. Substance dependent patients (N=360) at community-based treatment programs are randomly assigned to one of two conditions: (a) standard, non-CM treatment or (b) standard treatment plus prize CM delivered in groups. In the CM condition, patients earn the opportunity to win prizes for attending groups and submitting drug-free biological specimens. Substance use and psychosocial problems are measured at intake, month 1, month 3 (post treatment), and at 6-, 9-, and 12-month follow-up evaluations. We also assess patient characteristics that may be associated with improved outcomes within and across conditions.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Substance Abuse
Keywords
Contingency management, Substance abuse treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
312 (Actual)

8. Arms, Groups, and Interventions

Intervention Type
Behavioral
Intervention Name(s)
Contingency management
Intervention Description
Receive rewards (prizes) abstinence and attendance
Primary Outcome Measure Information:
Title
Drug use
Time Frame
baseline and at each follow-up
Title
Retention
Time Frame
each follow-up

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria: age > 18 years current DSM-IV diagnosis of cocaine, opioid or alcohol abuse or dependence willing to provide breath and urine samples for 12 weeks English speaking willing to sign informed consent Exclusion criteria: serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) dementia (<23 on the Mini Mental State Exam; Folstein et al. 1975) in recovery from pathological gambling
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nancy Petry, Ph.D.
Organizational Affiliation
UConn Health
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Connecticut Health Center
City
Farmington
State/Province
Connecticut
ZIP/Postal Code
06030
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Group-Based Contingency Management for Substance Abuse Treatment - 1

We'll reach out to this number within 24 hrs